ENHANCING SYNCOPE DIAGNOSTICS- COST-EFFECTIVENESS ANALYSIS OF AN IMPLANTABLE LOOP RECORDER STRATEGY VERSUS THE STANDARD OF CARE
Author(s)
Marianne Van Genugten, MSc, Reimbursement Manger1, Stelios Tsintzos, MD, MSc, Reimbursement analyst21Medtronic Trading NL B.V, Heerlen, DA, Netherlands; 2 Medtronic International Trading Sarl, Tolochenaz, Vaud, Switzerland
OBJECTIVES: Recent progress has enabled physicians to meet the challenge of syncope diagnosis and provide faster and better guided treatment to the patient. Syncope investigation traditionally included loosely-defined combinations of ECGs, Holter Monitors, Tilt Tests, EP Studies and Imaging Diagnostics. While tests were being performed, patients remained at risk of death, falls and fractures. We wanted to examine the potential cost-effectiveness of adding an Implantable Loop Recorder to the traditional clinical pathway. Clinical evidence increasingly demonstrates that ILR-enhanced diagnostics may enable physicians to achieve more clear diagnoses, at a fraction of the time. METHODS: We developed a decision-analytic model in Microsoft Excel. The model compares the cost-effectiveness of standard diagnostics with the one of ILR-enhanced diagnostic pathways. Number of positive diagnoses was used as the outcome measure. The number of diagnostic tests per patient and the yield of each test were found in published clinical literature. Cost data were taken from Dutch national sources. Sensitivity analyses were conducted using Monte Carlo Simulation. RESULTS: Literature and sensitivity analyses clearly show that the ILR-based pathway has a significantly higher capacity of providing a correct diagnosis (33.7% vs. 4.1%) within the same timeframe. The cost per diagnosis in the ILR-based pathway was slightly higher than the cost per diagnosis of more conventional care (approximately €1200 more needed per diagnosis with ILRs).CONCLUSIONS: ILRs can be considered an established, safe and efficient addition to syncope diagnostics. They provide physicians with excellent diagnostic yield, enabling timely and correct treatment of patients whose condition could remain undiagnosed. Cost per diagnosis demonstrates the cost-effectiveness of their use. Potentially, ILRs can also reduce time-to-diagnosis and operational expenditure of the hospital. Should that be the case, ILRs can be even more cost-effective while enabling more patients to get life-saving treatment faster.
Conference/Value in Health Info
2008-11, ISPOR Europe 2008, Athens, Greece
Value in Health, Vol. 11, No. 6 (November 2008)
Code
PCV48
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Cardiovascular Disorders